Blog
MGM Resorts Wants to Double Down on East Coast Gaming Market
MGM Resorts (NYSE: MGM) is betting big on East Coast gaming with a recent buyout of the half of Borgata it didn't own in Atlantic City, a resort near Washington D.C., and another under....
What Happened in the Stock Market Today
Stocks dipped Wednesday when the Federal Reserve announced plans to reduce its bond portfolio and hinted at another hike in the federal funds rate before the end of the year, but mostly recovered....
Amazon and Kohl's Just Got Even Closer
Earlier this month, Kohl's (NYSE: KSS) investors were encouraged by the department store chain's intriguing new partnership to sell smart-home products made by Amazon.com (NASDAQ: AMZN). But the....
Analyst: Tesla, Inc. Stock Could Fall 36%
Shares of Tesla (NASDAQ: TSLA) took a hit on Tuesday, falling about 3% after an analyst at Jefferies initiated coverage of the electric-car maker with an underperform rating, or a rating....
Here's Why Arbutus Biopharma Corp. Stock Soared Today
Shares of Arbutus Biopharma Corp. (NASDAQ: ABUS) rode some mighty coattails today. This morning, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced highly positive data for a candidate that....
Why I Sold These 2 Stocks in September
It's been one heck of an eight-year bull market. Many professional investors, such as Oaktree's Howard Marks, are cautioning that the market has gotten ahead of itself and that stocks are overpriced
Why BlackBerry, Plug Power, and USG Jumped Today
The stock market mostly treaded water on Wednesday, as investors were largely content to wait and see what comes next for the U.S. economy. The Federal Reserve concluded its two-day meeting....
Why Plug Power Inc's Shares Popped 12% Today
Shares of hydrogen fuel-cell company Plug Power Inc (NASDAQ: PLUG) jumped as much as 12% in trading on Wednesday after the company's chairman bought $426,000 worth of stock. At 3:25 p.m. EDT,....
The 3 Stocks on the MFM Team's Radar
In this segment from the Motley Fool Money radio show, host Chris Hill asks Supernova and Million Dollar Portfolio's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options'....
First Solar Has a Lot Riding on Proposed Solar Tarrifs
Solar companies and investors will likely learn late this week whether the Section 201 trade case filed by Suniva and joined by SolarWorld will be moving forward, recommending tariffs or other....
Is Nestle Taking Aim at Starbucks' Territory?
It's hard to imagine any company being a real threat to a chain as dominant as Starbucks (NASDAQ: SBUX), but the restaurant industry is a fickle space. In this segment from the Motley Fool Money....
Why a Notoriously Outspoken Analyst Just Gave Big Banks Some Love
In this segment from the Motley Fool Money radio show, host Chris Hill, Supernova and Million Dollar Portfolio's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options' Jeff....
Is SharkNinja a Real Danger to iRobot?
In this segment from the Motley Fool Money radio show, host Chris Hill, Supernova and Million Dollar Portfolio's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options' Jeff....
Amazon.com Reportedly Working on Smart Glasses
As the augmented reality (AR) market prepares to catch a second wind thanks to Apple (NASDAQ: AAPL) and Facebook (NASDAQ: FB), another tech titan may be preparing to jump in: Amazon.com (NASDAQ:....
Is This Beaten-Down 5.5% Yielder Now a Buy?
Before the oil market downturn, Plains All American Pipeline (NYSE: PAA) was a high-powered growth stock. Over the five-year period from 2009 to 2014, the oil pipeline company delivered a nearly....
Should You Buy Rite Aid Stock Now That the Walgreens Deal Is Done?
Like the series finale of a long-running TV drama, the final act in the deal between Rite Aid Corporation (NYSE: RAD) and Walgreens Boots Alliance (NASDAQ: WBA) had one last plot twist.The U.S.....
Why Oracle Shareholders Had a Terrible, Horrible, No Good, Very Bad Day
In this segment from the Motley Fool Money radio show, host Chris Hill, Million Dollar Portfolio's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options' Jeff Fischer drill....
Why This Mine Is Critical to Franco-Nevada's Future
The mining industry presents substantial risks to the companies that operate in it. Though some mines have much greater payoffs in production than expected, other sites that look extremely....
Alnylam Notches a Game-Changing RNAi Win
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is researching therapies that can treat genetic diseases by interfering with gene expression. Though Alnylam has yet to validate its approach with a....
Lots More Help Wanted: Target Will Add 100,000 Seasonal Workers
In this segment from the Motley Fool Money radio show, host Chris Hill, Supernova and Million Dollar Portfolio's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options' Jeff....
The Most Interesting Things About Apple's Reveal Last Week
In this segment from the Motley Fool Money radio show, host Chris Hill, Million Dollar Portfolio and Supernova's Matt Argersinger, Total Income's Ron Gross, and Motley Fool Pro and Options' Jeff....
How Does Holly Energy Partners' High-Yield Partnership Hold Up to Enterprise Products Partners?
Holly Energy Partners, L.P. (NYSE: HEP) has a roughly 7.3% distribution yield. That's higher than that of many of its peers, including industry giant Enterprise Products Partners L.P. (NYSE: EPD),....
Following in Fitbit's Footsteps, Apple Shares Fall on Lackluster Apple Watch Series 3 Reviews
Yesterday was Fitbit's turn for shares to fall on lukewarm reviews of its all-important Ionic smartwatch. Today, it's Apple's (NASDAQ: AAPL) turn. The stock was down by 2% around 12:40 p.m. EDT....
3 Growth Stocks to Dive Into Now
Growth stocks can build your personal wealth quickly -- but they are a virtual minefield full of overpriced stocks and short-lived trends. With that in mind, we asked a handful of Motley Fool....
Why Alnylam Pharmaceuticals, Inc. Skyrocketed and Ionis Pharmaceuticals Inc Sank Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) is up more than 40% at 11:53 a.m. EDT after the company released positive phase 3 trial data for the Apollo trial testing its RNAi drug patisiran in patients....